Your browser doesn't support javascript.
loading
Cardiovascular and renal benefits of dapagliflozin in patients with short and long-standing type 2 diabetes: Analysis from the DECLARE-TIMI 58 trial.
Bajaj, Harpreet S; Raz, Itamar; Mosenzon, Ofri; Murphy, Sabina A; Rozenberg, Aliza; Yanuv, Ilan; Bhatt, Deepak L; Leiter, Lawrence A; McGuire, Darren K; Wilding, John P H; Gause-Nilsson, Ingrid A M; Sabatine, Marc S; Wiviott, Stephen D; Cahn, Avivit.
Afiliação
  • Bajaj HS; LMC Diabetes and Endocrinology, Brampton, Ontario, Canada.
  • Raz I; Leadership Sinai Center for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Mosenzon O; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Murphy SA; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Rozenberg A; Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Yanuv I; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Bhatt DL; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Leiter LA; Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • McGuire DK; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Wilding JPH; Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Gause-Nilsson IAM; Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK.
  • Sabatine MS; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Wiviott SD; Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Cahn A; Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Diabetes Obes Metab ; 22(7): 1122-1131, 2020 07.
Article em En | MEDLINE | ID: mdl-32090404

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Isquemia Encefálica / Acidente Vascular Cerebral / Diabetes Mellitus Tipo 2 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Isquemia Encefálica / Acidente Vascular Cerebral / Diabetes Mellitus Tipo 2 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá